- BMY has 11x the normal benchmarked social activity for this time of the day compared to its average of 6.68 mentions/day.
- BMY has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $500.3 million.
Identifying stocks with 'Unusual Social Activity' tends to be a valuable process for traders looking to capitalize on the 'talk of the town' stocks that are basking in far more attention from the StockTwits financial community than normal. Good press? Bad press? It ultimately doesn't matter if it's good or bad if you know how to trade around the sentiment. Certain hedge funds use such data for their proprietary algorithms and it is not uncommon to see shared social sentiment play itself out in a stock's price trend. EXCLUSIVE OFFER: Get the inside scoop on opportunities in BMY with the Ticky from Trade-Ideas. See the FREE profile for BMY NOW at Trade-Ideas More details on BMY: Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The stock currently has a dividend yield of 2.4%. BMY has a PE ratio of 59. Currently there are 7 analysts that rate Bristol-Myers Squibb Company a buy, no analysts rate it a sell, and 6 rate it a hold. The average volume for Bristol-Myers Squibb Company has been 5.9 million shares per day over the past 30 days. Bristol-Myers Squibb has a market cap of $104.6 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.04 and a short float of 1.5% with 2.71 days to cover. Shares are down 8.9% year-to-date as of the close of trading on Wednesday.